Quest Diagnostics Statistics
Share Statistics
Quest Diagnostics has 111.61M shares outstanding. The number of shares has increased by 0.82% in one year.
| Shares Outstanding | 111.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.27% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 111.06M |
| Failed to Deliver (FTD) Shares | 18.25K |
| FTD / Avg. Volume | 2.23% |
Short Selling Information
The latest short interest is 1.91M, so 1.71% of the outstanding shares have been sold short.
| Short Interest | 1.91M |
| Short % of Shares Out | 1.71% |
| Short % of Float | 1.72% |
| Short Ratio (days to cover) | 2.13 |
Valuation Ratios
The PE ratio is 18.08 and the forward PE ratio is 16.57. Quest Diagnostics's PEG ratio is 0.43.
| PE Ratio | 18.08 |
| Forward PE | 16.57 |
| PS Ratio | 1.67 |
| Forward PS | 1.6 |
| PB Ratio | 2.45 |
| P/FCF Ratio | 17.87 |
| PEG Ratio | 0.43 |
Enterprise Valuation
Quest Diagnostics has an Enterprise Value (EV) of 20.13B.
| EV / Earnings | 23.57 |
| EV / Sales | 2.18 |
| EV / EBITDA | 11.62 |
| EV / EBIT | 15.95 |
| EV / FCF | 23.29 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.31 |
| Quick Ratio | 1.2 |
| Debt / Equity | 0.75 |
| Total Debt / Capitalization | 42.77 |
| Cash Flow / Debt | 0.27 |
| Interest Coverage | 7.74 |
Financial Efficiency
Return on equity (ROE) is 0.14% and return on capital (ROIC) is 8.27%.
| Return on Equity (ROE) | 0.14% |
| Return on Assets (ROA) | 0.06% |
| Return on Capital (ROIC) | 8.27% |
| Revenue Per Employee | 185.04K |
| Profits Per Employee | 17.08K |
| Employee Count | 50.00K |
| Asset Turnover | 0.66 |
| Inventory Turnover | 33.11 |
Taxes
| Income Tax | 248.00M |
| Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 7.03% in the last 52 weeks. The beta is 0.89, so Quest Diagnostics's price volatility has been higher than the market average.
| Beta | 0.89 |
| 52-Week Price Change | 7.03% |
| 50-Day Moving Average | 157.07 |
| 200-Day Moving Average | 146.75 |
| Relative Strength Index (RSI) | 40.53 |
| Average Volume (20 Days) | 817.79K |
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 9.25B and earned 854.00M in profits. Earnings per share was 7.59.
| Revenue | 9.25B |
| Gross Profit | 2.96B |
| Operating Income | 1.26B |
| Net Income | 854.00M |
| EBITDA | 1.73B |
| EBIT | 1.26B |
| Earnings Per Share (EPS) | 7.59 |
Balance Sheet
The company has 686.00M in cash and 5.50B in debt, giving a net cash position of -4.81B.
| Cash & Cash Equivalents | 686.00M |
| Total Debt | 5.50B |
| Net Cash | -4.81B |
| Retained Earnings | 8.82B |
| Total Assets | 16.09B |
| Working Capital | 531.00M |
Cash Flow
In the last 12 months, operating cash flow was 1.27B and capital expenditures -408.00M, giving a free cash flow of 864.00M.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -408.00M |
| Free Cash Flow | 864.00M |
| FCF Per Share | 7.71 |
Margins
Gross margin is 3.20K%, with operating and profit margins of 1.36K% and 923%.
| Gross Margin | 3.20K% |
| Operating Margin | 1.36K% |
| Pretax Margin | 1.22K% |
| Profit Margin | 923% |
| EBITDA Margin | 18.72% |
| EBIT Margin | 13.64% |
| FCF Margin | 9.34% |
Dividends & Yields
DGX pays an annual dividend of $3, which amounts to a dividend yield of 1.99%.
| Dividend Per Share | $3.00 |
| Dividend Yield | 1.99% |
| Dividend Growth (YoY) | 5.63% |
| Payout Ratio | 40.32% |
| Earnings Yield | 4.99% |
| FCF Yield | 5.09% |
Analyst Forecast
The average price target for DGX is $170, which is 11.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $170 |
| Price Target Difference | 11.9% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
Stock Splits
The last stock split was on Jun 21, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 21, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.82 |
| Piotroski F-Score | 5 |